Signature Equity Partners’s Tenet Healthcare THC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.87K Sell
10
-6
-38% -$1.1K ﹤0.01% 1190
2026
Q1
$3.02K Sell
16
-42
-72% -$8.85K ﹤0.01% 1056
2025
Q4
$11.5K Buy
+58
New +$11.7K 0.01% 787

Other funds holding THC

Signature Equity Partners's THC Position: Q2 2026 in Review

Signature Equity Partners reduced its Tenet Healthcare (THC) stake by 38% in Q2 2026, selling an estimated $1.1K and leaving 10 shares worth $1.87K. The position accounts for ﹤0.01% of the portfolio, ranked #1190.

Signature Equity Partners first reported a position in THC in Q4 2025 and has held it in 3 quarters since. The position peaked at $11.5K in Q4 2025. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.

  • Signature Equity Partners held 10 shares of Tenet Healthcare worth $1.87K as of Q2 2026.
  • Signature Equity Partners sold 6 Tenet Healthcare shares in Q2 2026, an estimated $1.1K.
  • Tenet Healthcare made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #1190 holding.
  • Signature Equity Partners first reported a position in Tenet Healthcare in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's Tenet Healthcare position peaked at $11.5K in Q4 2025.
  • 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.